Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GeneGo has reported a five year, E25 million, multi-party program with the Netherlands Toxicogenomics Center or (NTC) for the use of toxicogenomics to develop highly predictive omics-based screens.
Subscribe to our email newsletter
These screens will be used for the in depth evaluation of chemical safety for human health, replacing, reducing or refining animal experiments, and improving the scientific basis of chemical risk assessment.
The NTC will use GeneGo’s MetaCore and MetaDrug systems biology data analysis platform to coordinate, visualize and interpret chemical, metabolomic, proteomic and gene expression data generated by the project members, and to identify the key biological functions and pathways contributing to the adverse effects of xenobiotic exposure.